The pharmaceutical industry in India is a rapidly evolving and high-growth sector, with executive compensation reflecting significant disparities between multinational corporations (MNCs) and homegrown Indian firms. With rising talent demands, innovation cycles, and global competitiveness, leadership pay structures have seen steady and notable increases in recent years. This blog provides an insightful overview of the executive pay landscape in India’s pharmaceutical companies, comparing MNCs with large Indian firms, and highlights key trends shaping compensation in 2025.
Salary Trends Since 2020
Since 2020, executive salaries across the pharma sector have risen approximately 9-10% annually, outpacing many other Indian industries. For example, Vice Presidents in pharma MNCs had an average salary of about ₹30 lakhs in 2020, which has climbed to ₹34–54 lakhs in 2025, with median pay around ₹38 lakhs. This reflects sector resilience underpinned by healthcare innovation and strong talent competition. 6figr+1​
Free Membership Required
You must be a Free member to access this content.
